KL and pancreatic adenocarcinoma: In pancreatic adenocarcinoma (PAAD), nicotinamide mononucleotide adenylyltransferase 1 (NMNAT1) is modified by Kla, enhancing its nuclear localization and enzymatic activity, thereby supporting the nuclear NAD+ salvage pathway and facilitating cancer progression [159].